slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,369
Current window 32,881-32,910
Pages 1,379
Rows per page 30
Component
32,881-32,910 of 41,369
07
Aeglea BioTherapeutics | Investor Presentation Deck | 56 slidesAeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Golden Circle1 hit
24
The chart compares benchmark induction remission rates with vedolizumab exposure quartiles.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
34
Includes visual representation of antibody binding mechanisms.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Evidence1 hit
40
The chart uses a waterfall-style logic to show the additive effect of the combination therapy.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Evidence1 hit
45
The slide uses a comparative framework to validate the efficacy of CDx-guided patient selection.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Action1 hit
48
The slide uses a table-based timeline structure to map specific drug candidates (SPY001-004) to expected regulatory and clinical milestones.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Action1 hit
49
The chart uses a custom range bar (min/max) with markers for IPO and Today's market cap.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Action1 hit
50
The slide uses a timeline-based comparison to suggest that Spyre's assets are on a similar trajectory to high-value acquired assets.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Action1 hit
53
Aeglea BioTherapeutics | Investor Presentation Deck | 56 slidesAeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Action1 hit
56
Includes two distinct chart types: a scatter plot for half-life correlation and bar charts for ADA rates.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Action1 hit
06
The slide uses a split-screen layout to contrast established proof-of-concept (left) with future development plans (right).argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · RoadmapLoop · Maturity Curve1 hit
08
Includes a callout for cash position at end of Q2 2023.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · KPIsLoop · Pareto Focus1 hit
13
The slide uses a patient story to humanize the clinical goals of minimizing burden and achieving sustained responses.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations 1 hit
11
The table includes hazard ratios, p-values, and mean changes from baseline for CIDP disease progression and functional scores.argenx SE | Results Presentation Deck | 16 slides · argenx
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
13
Uses a 'before-after' framing to contrast legacy treatments (IVIg, Steroids, PLEX) with the new product's benefits.argenx SE | Results Presentation Deck | 16 slides · argenx
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
05
Includes a waterfall-style comparison for revenue growth and stacked bar charts for revenue segmentation.AstraZeneca | Results Presentation Deck | 44 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Pattern Hunter1 hit
07
The chart displays Total Revenue (USD million), Growth vs. PY (USD million), and Growth vs. PY (CER%).AstraZeneca | Results Presentation Deck | 44 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Pattern Hunter1 hit
08
The slide uses a two-column layout to contrast pipeline scale with specific recent trial successes.AstraZeneca | Results Presentation Deck | 44 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Pattern Hunter1 hit
18
The slide uses a matrix-like structure to categorize trials by cancer type and development strategy (monotherapy vs. combinations vs. biomarker assessment).AstraZeneca | Results Presentation Deck | 44 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
21
The slide uses three donut charts to visualize revenue sources, patient share by indication, and market share.AstraZeneca | Results Presentation Deck | 44 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
26
Includes a process diagram for complimentary mechanisms of ATTR-CM treatment.AstraZeneca | Results Presentation Deck | 44 slides · AstraZeneca
Conference presentation Investor relations 1 hit
29
The slide uses a three-column layout to categorize decarbonization efforts into specific scopes and programs.AstraZeneca | Results Presentation Deck | 44 slides · AstraZeneca
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
30
The slide uses a grid layout to present clinical trial assets on the left and corporate KPIs on the right.AstraZeneca | Results Presentation Deck | 44 slides · AstraZeneca
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
16
The slide uses a split-screen layout comparing quantitative sell-out data with qualitative/quantitative brand health metrics.Crocs | Results Presentation Deck | 40 slides · Crocs
Conference presentation Investor relations Beat · SatisfactionLoop · Before After1 hit
08
The slide uses a comparison framework to contrast existing treatments for other conditions with the lack of treatments for FSAD.Dare Bioscience | Investor Presentation Deck | 27 slides · Daré Bioscience
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
10
Uses a flywheel framework concept to explain the synergy between grocery and restaurant orders.Deliveroo | Investor Event Presentation Deck | 27 slides · Deliveroo
Conference presentation Investor relations 1 hit
33
Includes footnotes referencing slides 35 and 36.Deutsche Bank | Fixed Income Presentation Deck | 38 slides · Deutsche Bank
Conference presentation Investor relations 1 hit
27
Includes footnotes referencing slides 40 and 41.Deutsche Bank | Results Presentation Deck | 43 slides · Deutsche Bank
Conference presentation Investor relations 1 hit
31
Notes: for footnotes refer to slides 40 and 41Deutsche Bank | Results Presentation Deck | 43 slides · Deutsche Bank
Conference presentation Investor relations 1 hit
15
The slide uses visual product placement to illustrate innovation strategy.Diageo | Results Presentation Deck | 40 slides · Diageo
Conference presentation Investor relations Beat · EvidenceLoop · Jobs To Be Done1 hit